Gartner, Inc. SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
Gartner, Inc. (IT) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense of -$1.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense · last filed 2026-02-12
- Gartner, Inc. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2025 was -$1.00M, a 120.00% decline from fiscal 2024.
- Gartner, Inc. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2024 was $5.00M, a 30.56% decline from fiscal 2023.
- Gartner, Inc. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2023 was $7.20M, a 7.69% decline from fiscal 2022.
- Gartner, Inc. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2022 was $7.80M, a 178.57% increase from fiscal 2021.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month |
|---|---|
| 2025-12-31 | -$1.00M 10-K · filed 2026-02-12 |
| 2024-12-31 | $5.00M 10-K · filed 2026-02-12 |
| 2023-12-31 | $7.20M 10-K · filed 2026-02-12 |
| 2022-12-31 | $7.80M 10-K · filed 2025-02-13 |
| 2021-12-31 | $2.80M 10-K · filed 2024-02-15 |
| 2020-12-31 | $16.00M 10-K · filed 2023-02-16 |
| 2019-12-31 | $14.00M 10-K · filed 2022-02-23 |
| 2018-12-31 | $12.50M 10-K · filed 2021-02-24 |
| 2017-12-31 | $16.60M 10-K · filed 2020-02-19 |
| 2016-12-31 | $4.75M 10-K · filed 2019-02-22 |
| 2015-12-31 | $3.48M 10-K · filed 2018-02-22 |
| 2014-12-31 | $2.95M 10-K · filed 2017-02-22 |
| 2013-12-31 | $2.35M 10-K · filed 2016-02-24 |
| 2012-12-31 | $1.93M 10-K · filed 2015-02-27 |
| 2011-12-31 | $930.00K 10-K · filed 2014-02-26 |
| 2010-12-31 | $800.00K 10-K · filed 2013-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |